Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
---|
08/07/2007 | US7252974 Human growth gene and short stature gene region |
08/07/2007 | US7252819 Methods and compositions for correction of cardiac conduction disturbances |
08/07/2007 | US7252654 Apparatus with weeping tip and method of use |
08/07/2007 | CA2376379C Modified chimeric polypeptides with improved pharmacokinetic properties |
08/07/2007 | CA2286304C Pca3, pca3 genes, and methods of use |
08/07/2007 | CA2246568C Phosphatidyl oligoglycerols |
08/07/2007 | CA2182388C Process for producing endotoxin-free or endotoxin-poor nucleic acids and/or oligonucleotides for gene therapy |
08/07/2007 | CA2132265C Anti-sense oligonucleotides against hsv-1, and their preparation |
08/07/2007 | CA2062829C Nucleotides sequences derived from the genome of type hiv-1, hiv-2 and siv retroviruses, and their applications especially for the amplification the genomes of these retroviruses and for in vitro diagnosis of infections due to these viruses |
08/02/2007 | WO2007087544A2 Novel compositions of chemically modified small interfering rna |
08/02/2007 | WO2007087451A2 Compositions and methods for enhancing discriminatory rna interference |
08/02/2007 | WO2007087415A2 Compositions and methods for inhibition leukocyte function |
08/02/2007 | WO2007087412A2 Tat-036 and methods of assessing and treating cancer |
08/02/2007 | WO2007087370A2 Tat-038 and methods of assessing and treating cancer |
08/02/2007 | WO2007087367A2 Methods and compositions for modulating the mobilization of stem cells |
08/02/2007 | WO2007087178A2 Vaccines and immunotherapeutics using codon optimized il-15 and methods for using the same |
08/02/2007 | WO2007087113A2 Natural antisense and non-coding rna transcripts as drug targets |
08/02/2007 | WO2007086923A2 Controlled and sustained gene transfer mediated by thiol-modified polymers |
08/02/2007 | WO2007086526A1 Gene polymorphism and use thereof |
08/02/2007 | WO2007061627A3 Direct dna delivery to bone cells |
08/02/2007 | WO2007057618A3 Inducible promoters |
08/02/2007 | WO2006048017A8 Lipid-based drug delivery systems containing unnatural phospholipase a2 degradable lipid derivatives and the therapeutic uses thereof |
08/02/2007 | WO2005096781A3 Methods and compositions for treating gain-of-function disorders using rna interference |
08/02/2007 | US20070180545 TAT-031 and methods of assessing and treating cancer |
08/02/2007 | US20070180544 Methods and compositions for autism spectrum disorders |
08/02/2007 | US20070180543 Non-steroidal anti-inflammatory drug activated gene with anti-tumorigenic properties |
08/02/2007 | US20070179113 GM-CSF gene therapy for Crohn's disease using an improved regulated expression system |
08/02/2007 | US20070179112 Polymeric nucleoside prodrugs |
08/02/2007 | US20070179111 Methods of treating proteinuria by reducing double-stranded dna antibodies |
08/02/2007 | US20070179110 Expression of immunogenic substances |
08/02/2007 | US20070179109 Double strand compositions comprising differentially modified strands for use in gene modulation |
08/02/2007 | US20070179108 Double strand compositions comprising differentially modified strands for use in gene modulation |
08/02/2007 | US20070179107 Double strand compositions comprising differentially modified strands for use in gene modulation |
08/02/2007 | US20070179106 Double strand compositions comprising differentially modified strands for use in gene modulation |
08/02/2007 | US20070179105 Method and means for treating solid tumors |
08/02/2007 | US20070179104 Moderator of gene expression of Winged helix nude; small nucleic acidsl alopecia; autoimmune disease |
08/02/2007 | US20070179103 Immunostimulatory oligonucleotide multimers |
08/02/2007 | US20070179102 Methods and compositions for the treatment and diagnosis of pain disorders using 9805, 2047, 46566, 57749, 577, 20739, 57145, 1465, 1587, 2146, 2207, 32838, 336 or 52908 |
08/02/2007 | US20070179101 biodrug as antitumor agent, a vaccine adjuvant for infections and cancers, and antiallergy agents |
08/02/2007 | US20070179100 Protected monomers |
08/02/2007 | US20070179095 orally administering to a patient a therapeutically effective amount of factor VIII in water to induce oral tolerance and supply exogenous factor VIII ( not present in liposome), for increasing hemostasis in the patient having hemophilia A; obtained from milk of a non-human transgenic mammal |
08/02/2007 | US20070179091 Hedgehog Kinases and Their Use in Modulating Hedgehog Signaling |
08/02/2007 | US20070179089 Structure of SOCS and uses thereof |
08/02/2007 | US20070179087 Method for treating inflammatory diseases using heat shock proteins |
08/02/2007 | US20070179083 Covalent attachment of ligands to nucleophilic proteins guided by non-covalent binding |
08/02/2007 | US20070178592 Lentiviral vectors featuring liver specific transcriptional enhancer and methods of using same |
08/02/2007 | US20070178585 Eukaryotic cell overexpressing an endogenous gene; introducing a vector containing a transcriptional regulatory sequence into the cell, allowing the vector to integrate into the genome of the cell by non-homologous recombination |
08/02/2007 | US20070178555 Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the CNS |
08/02/2007 | US20070178553 Mammalian T-type calcium channels |
08/02/2007 | US20070178114 Novel kallikrein gene |
08/02/2007 | US20070178111 Identification and application of antibiotic synergy |
08/02/2007 | US20070178110 Surface-located campylobacter jejuni polypeptides |
08/02/2007 | US20070178108 Colon Specific Gene and Protein and Cancer |
08/02/2007 | US20070178107 Method and means for treating solid tumors |
08/02/2007 | US20070178105 FHIT proteins and nucleic acids and methods based thereon |
08/02/2007 | US20070178104 Methods and means for treating solid tumors |
08/02/2007 | US20070178087 Method for Treating Immune Dysfunction by Regulation of CD40 Ligand Expression |
08/02/2007 | US20070178082 Stabilized single domain antibodies |
08/02/2007 | US20070178077 Method for in vitro preconditioning of myoblasts before transplantation |
08/02/2007 | US20070178076 Porous membrane device that promotes the differentiation of monocytes into dendritic cells |
08/02/2007 | US20070178075 Side Population Cells in Cardiac Repair |
08/02/2007 | US20070178071 Stem-cell, precursor cell, or target cell-based treatment of multiorgan failure and renal dysfunction |
08/02/2007 | US20070178069 Herpes simplex virus vector |
08/02/2007 | US20070178068 Compositions and methods for regulating complement system |
08/02/2007 | US20070178067 System and method for cytological analysis by raman spectroscopic imaging |
08/02/2007 | US20070178066 Pathotropic targeted gene delivery system for cancer and other disorders |
08/02/2007 | US20070178065 Neutralizing factors as vaccine adjuvants |
08/02/2007 | US20070178064 Use to enhance apoptosis; antiproliferative agents; IAP (inhibitor-of apoptosis) |
08/02/2007 | CA2640087A1 Methods and compositions for modulating the mobilization of stem cells |
08/02/2007 | CA2636867A1 Vaccines and immunotherapeutics using codon optimized il-15 and methods for using the same |
08/02/2007 | CA2597724A1 Cationic lipids and formulated molecular compositions containing them |
08/01/2007 | EP1813676A2 Retroviral vectors pseudotyped with influenza virus hemagglutin for gene delivery |
08/01/2007 | EP1813626A1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof, antigens recognized thereby and cells obtained thereby |
08/01/2007 | EP1813289A1 Medicinal composition for treating cancer or diabetes |
08/01/2007 | EP1812864A2 Multifunctional nanoparticles conjugates and their use |
08/01/2007 | EP1812564A2 Defective influenza virus particles |
08/01/2007 | EP1812560A1 Retina-specific cells differentiated in vitro from bone marrow stem cells, the production thereof and their use |
08/01/2007 | EP1812077A2 Modulators of epha2 and ephrina1 for the treatment of fibrosis-related disease |
08/01/2007 | EP1812075A1 Antisense oligonucleotides for treating allergy and neoplastic cell proliferation |
08/01/2007 | EP1556494B1 Bicistronic vector encoding a vegf and an fgf, use thereof |
08/01/2007 | EP1507561A4 Compositions for delivering nucleic acids to cells |
08/01/2007 | EP1185615B1 Recombinant influenza viruses for vaccines and gene therapy |
08/01/2007 | EP1082410B1 Human cd45+ and/or fibroblast + mesenchymal stem cells |
08/01/2007 | EP0884947B1 Dna vaccination for induction of suppressive t cell response |
08/01/2007 | CN1329513C Avian polynucleotide vaccine formula for anti pig's diseases |
08/01/2007 | CN1329512C Modulator of TNF/NGF superfamily receptors and soluble oligomeric TNF/NGF superfamily receptors |
08/01/2007 | CN1329409C Modulation of the expression of genes dependent on STAT-1 |
08/01/2007 | CN1329083C Method for degrading AML 1-ETO fusion protein and used reagent |
08/01/2007 | CN101010073A Nanocoating for improving biocompatibility of medical implants |
08/01/2007 | CN101007839A Nucleic acid molecule RTN4BSR12 and its application in preparing anticancer medicine |
08/01/2007 | CN101007838A Nucleic acid molecule RTN4BSR22 and its application in preparing anticancer medicine |
08/01/2007 | CN101007837A Nucleic acid molecule RTN4BSR42 and its application in preparing anticancer medicine |
08/01/2007 | CN101007836A Nucleic acid molecule RTN4BSR52 and its application in preparing anticancer medicine |
08/01/2007 | CN101007835A Nucleic acid molecule RTN4BSR5 and its application in preparing anticancer medicine |
08/01/2007 | CN101007834A Nucleic acid molecule RTN4BSR4 and its application in preparing anticancer medicine |
08/01/2007 | CN101007833A Nucleic acid molecule RTN4BSR3 and its application in preparing anticancer medicine |
08/01/2007 | CN101007832A Nucleic acid molecule RTN4BSR2 and its application in preparing anticancer medicine |
08/01/2007 | CN101007831A Nucleic acid molecule RTN4BSR1and its application in preparing anticancer medicine |
08/01/2007 | CN101007027A Application method of neural regulation protein in the treatment of cardiovascular diseases and its composition |
07/31/2007 | US7250488 Transcriptional activation inhibitory protein |